ATXI - Avenue Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 7/9/2020
Current
3/31/202012/31/20199/30/20196/30/2019
Market Cap (intraday) 5
161.82M149.14M160.15M99.30M104.32M
Enterprise Value 3
155.25M140.40M146.41M83.85M74.88M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
N/AN/AN/AN/AN/A
Price/Book (mrq)
28.0321.9313.397.145.13
Enterprise Value/Revenue 3
N/AN/AN/AN/AN/A
Enterprise Value/EBITDA 6
-9.60-110.20-26.75-36.09-10.53

Trading Information

Stock Price History

Beta (5Y Monthly) 0.20
52-Week Change 358.96%
S&P500 52-Week Change 35.66%
52 Week High 311.83
52 Week Low 34.96
50-Day Moving Average 310.76
200-Day Moving Average 39.48

Share Statistics

Avg Vol (3 month) 365.94k
Avg Vol (10 day) 370.81k
Shares Outstanding 516.68M
Float 5.55M
% Held by Insiders 161.41%
% Held by Institutions 110.17%
Shares Short (Jun 14, 2020) 449.29k
Short Ratio (Jun 14, 2020) 40.94
Short % of Float (Jun 14, 2020) 42.03%
Short % of Shares Outstanding (Jun 14, 2020) 40.30%
Shares Short (prior month May 14, 2020) 439.37k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Mar 30, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-55.47%
Return on Equity (ttm)-121.58%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-15.88M
Diluted EPS (ttm)-0.97
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)6.57M
Total Cash Per Share (mrq)0.39
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)7.26
Book Value Per Share (mrq)0.35

Cash Flow Statement

Operating Cash Flow (ttm)-21.86M
Levered Free Cash Flow (ttm)-17.1M